Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...
Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...
Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...
Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...
Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
Ozempic is well-known for its ability to manage type 2 diabetes and aid weight loss. . But as more research emerges, additional health benefits of the GLP-1 drug are being uncovered. Previous studies ...
The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March ...